177 related articles for article (PubMed ID: 34807483)
1. FGFR2 loss sensitizes MYCN-amplified neuroblastoma CHP134 cells to CHK1 inhibitor-induced apoptosis. Ando K; Ohira M; Takada I; Cázares-Ordoñez V; Suenaga Y; Nagase H; Kobayashi S; Koshinaga T; Kamijo T; Makishima M; Wada S Cancer Sci; 2022 Feb; 113(2):587-596. PubMed ID: 34807483 [TBL] [Abstract][Full Text] [Related]
2. YAP1 Mediates Resistance to MEK1/2 Inhibition in Neuroblastomas with Hyperactivated RAS Signaling. Coggins GE; Farrel A; Rathi KS; Hayes CM; Scolaro L; Rokita JL; Maris JM Cancer Res; 2019 Dec; 79(24):6204-6214. PubMed ID: 31672841 [TBL] [Abstract][Full Text] [Related]
3. Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells. Int J Mol Sci; ; . PubMed ID: 31362335 [TBL] [Abstract][Full Text] [Related]